We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Sustained nicorandil administration reduces the infarct size in ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention Introduction.
- Authors
Shanjie Wang; Yu Duan; Xinyu Feng; Liang Liu; Zhaofeng Shi; Bo Wang; Chenhai Xia; Wanrong Man; Haichang Wang; Zhijing Zhao; Dongdong Sun
- Abstract
Objective: Currently, there is still no effective strategy to diminish the infarct size (IS) in patients with ST-segment elevation myocardial infarction (STEMI). According to a previous animal study, nicorandil treatment is a promising pharmaceutical treatment to limit the infarct area. In this study, we aim to investigate the effects of continual nicorandil administration on the IS and the clinical outcomes in patients with STEMI who underwent primary percutaneous coronary intervention (pPCI). Methods: One hundred seventeen patients with STEMI and undergoing pPCI were randomly divided into the sustained nicorandil group (5 mg, three times daily) or the control group (only single nicorandil before PCI). The primary endpoint was the IS, evaluated by single-photon emission computed tomography (SPECT) 3 months after pPCI. Results: Eighty-five patients completed the IS assessment via SPECT, and 99 participants were available for follow-up after 6 months. Finally, there was a statistical difference in the IS between the nicorandil and control groups {13% [interquartile range (IQR), 8-17] versus 16% [IQR, 12-20.3], p=0.027}. Additionally, we observed that maintained nicorandil administration significantly improved the left ventricular ejection fraction at 3 months and enhanced the activity tolerance (physical limitation and angina stability) at 6 months after PCI. Conclusion: Sustained nicorandil treatment reduced the IS and improved the clinical outcomes compared to the single nicorandil administration for patients with STEMI undergoing the pPCI procedure. Continuous cardioprotective therapy may be more beneficial for patients with STEMI.
- Subjects
VENTRICULAR ejection fraction; PERCUTANEOUS coronary intervention; MYOCARDIAL infarction
- Publication
Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi, 2019, Vol 21, Issue 3, p163
- ISSN
2149-2263
- Publication type
Article
- DOI
10.14744/AnatolJCardiol.2018.57383